Purdy, MacKenzie P.
Ducharme, Merrick
Haak, Andrew J.
Ravix, Jovanka
Tan, Qi
Sicard, Delphine
Prakash, Y. S.
Tschumperlin, Daniel J.
Stewart, Elizabeth A.
Article History
Received: 4 June 2019
Accepted: 12 September 2019
First Online: 13 February 2020
Compliance with Ethical Standards
: The protocol has been approved by the Mayo Clinic IRB (17-003124). All patient information was de-identified.
: Dr. Stewart reports personal fees from Bayer, personal fees from AbbVie, personal fees from Myovant, personal fees from UpToDate, personal fees from Med Learning Group, outside the submitted work; in addition, Dr. Stewart has a patent Methods and Compounds for Treatment of Abnormal Uterine Bleeding 6440445 issued.